Illumina Partners Advance Cancer Research with Multiomics Technologies
Studies demonstrate spatial transcriptomics, 5-base sequencing, and proteomics applications in oncology diagnostics and therapeutic development.
Latest Articles
Editor's Top Picks
Policy and Payment Gaps Limit Access to Critical Diagnostic Testing
A new analysis finds that policy and payment gaps are limiting access to diagnostics, with nearly half the world lacking adequate testing and reimbursement lagging behind advances in precision therapies.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Astorg to Acquire Thermo Fisher Scientific Microbiology Business
The acquisition will establish the microbiology unit as an independent platform focused on clinical diagnostic consumables and equipment.
Equipment & Supply Spotlight
Thermo Fisher Launches Thermal Cycler for Workflow Flexibility and Lab Automation
The system features advanced thermal technology and modular block configurations to support complex molecular biology protocols.
News, Know-How & Standards
Disease Detection & Understanding
Blood Test Predicts Metastatic Risk in Bladder Cancer Patients Who Keep Their Bladders
Circulating tumor DNA testing may help predict metastatic risk in muscle-invasive bladder cancer patients opting for bladder-sparing treatment, according to Fox Chase Cancer Center researchers, though additional biomarkers are needed for local recurrence.
